FCA
ETTX

FinTrust Capital Advisors’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

FinTrust Capital Advisors’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-654
Closed -$1K – 1348
2022
Q1 		$1K Hold
654
– – ﹤0.01% 1203
2021
Q4 		$1K Buy
+654
New +$1.77K ﹤0.01% 1169

Other funds holding ETTX

GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FinTrust Capital Advisors's ETTX Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2022, closing a stake of 654 shares — an estimated $1K sold.

FinTrust Capital Advisors first reported a position in ETTX in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 27 funds tracked by Wall St. Rank hold ETTX as of Q2 2022.

  • FinTrust Capital Advisors reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 654 Entasis Therapeutics Holdings Inc. shares in Q2 2022, an estimated $1K.
  • FinTrust Capital Advisors first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2021 and held it in 2 quarters.
  • FinTrust Capital Advisors's Entasis Therapeutics Holdings Inc. position peaked at $1K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.